Publications
Found 1 results
Filters: Author is S. Alam [Clear All Filters]
“Genetic polymorphism of the glutathione-S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population”, vol. 10, pp. 3038-3045, 2011.
, Abate-Shen C and Shen MM (2000). Molecular genetics of prostate cancer. Genes Dev. 14: 2410-2434.
http://dx.doi.org/10.1101/gad.819500
Adler V, Yin Z, Fuchs SY, Benezra M, et al. (1999). Regulation of JNK signaling by GSTp. EMBO J. 18: 1321-1334.
http://dx.doi.org/10.1093/emboj/18.5.1321
PMid:10064598 PMCid:1171222
Antognelli C, Mearini L, Talesa VN, Giannantoni A, et al. (2005). Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63: 240-251.
http://dx.doi.org/10.1002/pros.20184
PMid:15538743
Autrup JL, Thomassen LH, Olsen JH, Wolf H, et al. (1999). Glutathione S-transferases as risk factors in prostate cancer. Eur. J. Cancer Prev. 8: 525-532.
http://dx.doi.org/10.1097/00008469-199912000-00008
PMid:10643942
Bostwick DG, Burke HB, Djakiew D, Euling S, et al. (2004). Human prostate cancer risk factors. Cancer 101: 2371-2490.
http://dx.doi.org/10.1002/cncr.20408
PMid:15495199
Choi JY, Neuhouser ML, Barnett M, Hudson M, et al. (2007). Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol. Biomarkers Prev. 16: 1115-1120.
http://dx.doi.org/10.1158/1055-9965.EPI-07-0040
Debes JD, Yokomizo A, McDonnell SK, Hebbring SJ, et al. (2004). Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet. Cytogenet. 155: 82-86.
http://dx.doi.org/10.1016/j.cancergencyto.2004.03.015
PMid:15527908
Fleshner NE and Klotz LH (1998). Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev. 17: 325-330.
http://dx.doi.org/10.1023/A:1006118628183
PMid:10453275
Garcia-Saez I, Parraga A, Phillips MF, Mantle TJ, et al. (1994). Molecular structure at 1.8 Åof mouse liver class pi glutathione S-transferase complexed with S-(p-nitrobenzyl)glutathione and other inhibitors. J. Mol. Biol. 237: 298- 314.
http://dx.doi.org/10.1006/jmbi.1994.1232
PMid:8145243
Harries LW, Stubbins MJ, Forman D, Howard GC, et al. (1997). Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-644.
http://dx.doi.org/10.1093/carcin/18.4.641
PMid:9111193
Hayes JD and Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166.
http://dx.doi.org/10.1159/000028396
PMid:10971201
Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ, et al. (1998). π-class glutathione S-transferase: regulation and function. Chem. Biol. Interact. 111-112: 69-82.
http://dx.doi.org/10.1016/S0009-2797(97)00176-2
Hsing AW and Chokkalingam AP (2006). Prostate cancer epidemiology. Front. Biosci. 11: 1388-1413.
http://dx.doi.org/10.2741/1891
PMid:16368524
Jeronimo C, Varzim G, Henrique R, Oliveira J, et al. (2002). I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 11: 445-450.
PMid:12010858
Kelada SN, Kardia SL, Walker AH, Wein AJ, et al. (2000). The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol. Biomarkers Prev. 9: 1329-1334.
PMid:11142418
Konwar R, Manchanda PK, Chaudhary P, Nayak VL, et al. (2010). Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population. Asian Pac. J. Cancer Prev. 11: 1067-1072.
PMid:21133626
Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, et al. (2001). Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 11: 325-330.
http://dx.doi.org/10.1097/00008571-200106000-00007
PMid:11434510
McCarty KM, Santella RM, Steck SE, Cleveland RJ, et al. (2009). PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ. Health Perspect. 117: 552-558.
PMid:19440493 PMCid:2679598
Mir O, Alexandre J, Tran A, Durand JP, et al. (2009). Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Ann. Oncol. 20: 736-740.
http://dx.doi.org/10.1093/annonc/mdn698
PMid:19223573
Miyake H, Hara I, Kamidono S and Eto H (2004). Oxidative DNA damage in patients with prostate cancer and its response to treatment. J. Urol. 171: 1533-1536.
http://dx.doi.org/10.1097/01.ju.0000116617.32728.ca
PMid:15017214
Mo Z, Gao Y, Cao Y, Gao F, et al. (2009). An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 69: 662-688.
http://dx.doi.org/10.1002/pros.20907
PMid:19143011
Nakazato H, Suzuki K, Matsui H, Koike H, et al. (2003). Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res. 23: 2897-2902.
PMid:12926131
Ntais C, Polycarpou A and Ioannidis JP (2005). Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 14: 176-181.
PMid:15668493
Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6: 733-743.
PMid:9298582
Ryberg D, Skaug V, Hewer A, Phillips DH, et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289.
http://dx.doi.org/10.1093/carcin/18.7.1285
PMid:9230269
Shepard TF, Platz EA, Kantoff PW, Nelson WG, et al. (2000). No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol. Biomarkers Prev. 9: 1267-1268.
PMid:11097238
Sikka SC (2003). Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention - a mechanistic approach. Curr. Med. Chem. 10: 2679-2692.
http://dx.doi.org/10.2174/0929867033456341
PMid:14529458
Sreeja L, Syamala V, Hariharan S, Syamala VS, et al. (2008). Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. J. Exp. Ther. Oncol. 7: 73-85.
PMid:18472644
Srivastava DS, Mandhani A, Mittal B and Mittal RD (2005). Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int. 95: 170-173.
http://dx.doi.org/10.1111/j.1464-410X.2005.05271.x
PMid:15638917
Steinhoff C, Franke KH, Golka K, Thier R, et al. (2000). Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch. Toxicol. 74: 521-526.
http://dx.doi.org/10.1007/s002040000161
PMid:11131031
Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, et al. (2005). Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population. Asian Pac. J. Cancer Prev. 6: 309-314.
PMid:16235991
Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, et al. (1999). Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9: 333-340.
http://dx.doi.org/10.1097/00008571-199906000-00008
PMid:10471065
Waris G and Ahsan H (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 5: 14.
http://dx.doi.org/10.1186/1477-3163-5-14
PMid:16689993 PMCid:1479806
Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, et al. (1994). Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem. 224: 893-899.
http://dx.doi.org/10.1111/j.1432-1033.1994.00893.x
PMid:7925413